Search

Ann M Lees

from Brookline, MA
Age ~89

Ann Lees Phones & Addresses

  • 203 Clinton Rd, Brookline, MA 02445 (617) 731-5779
  • 203 Clinton Rd #203, Brookline, MA 02445
  • 139 Main St, Cambridge, MA 02142
  • 43 Hammett Rd, Chilmark, MA 02535 (508) 645-9024

Resumes

Resumes

Ann Lees Photo 1

Individual & Family Services Professional

View page
Location:
Greater Boston Area
Industry:
Individual & Family Services
Ann Lees Photo 2

Ann Lees

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ann M. Lees
Manager
ATHEREX, LLC
Commercial Physical Research
46 Bedford Rd, Lincoln, MA 01773
PO Box 6106, Lincoln Center, MA 01773
(617) 577-7900

Publications

Isbn (Books And Publications)

Regional Security Development and Stability in Southeast Asia

View page
Author

Ann Lees

ISBN #

0566040107

Us Patents

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
6355451, Mar 12, 2002
Filed:
Nov 26, 1997
Appl. No.:
08/979608
Inventors:
Ann M. Lees - Brookline MA
Robert S. Lees - Brookline MA
Simon W. Law - Lexington MA
Anibal A. Arjona - Boston MA
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
C12P 2106
US Classification:
435 691, 536 221, 536 235
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
6605588, Aug 12, 2003
Filed:
Mar 2, 2000
Appl. No.:
09/517849
Inventors:
Ann M. Lees - Brookline MA
Robert S. Lees - Brookline MA
Simon W. Law - Lexington MA
Anibal A. Arjona - Boston MA
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
A01N 3718
US Classification:
514 2, 4241851, 435 6, 435 71, 435 691, 530350, 514814
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
6632923, Oct 14, 2003
Filed:
Jul 14, 2000
Appl. No.:
09/616289
Inventors:
Ann M. Lees - Brookline MA
Robert S. Lees - Brookline MA
Simon W. Law - Lexington MA
Anibal A. Arjona - Boston MA
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
C07K 1400
US Classification:
530350, 530300, 530359, 435440, 435441
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
6878817, Apr 12, 2005
Filed:
Oct 12, 2001
Appl. No.:
09/976740
Inventors:
Ann M. Lees - Brookline MA, US
Robert S. Lees - Brookline MA, US
Simon W. Law - Lexington MA, US
Anibal A. Arjona - Boston MA, US
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
C07H021/04
C07K001/00
A61K038/00
C12N015/00
US Classification:
536 235, 536 231, 530300, 530350, 530359, 435440, 435441
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
7244410, Jul 17, 2007
Filed:
Jul 9, 2003
Appl. No.:
10/616187
Inventors:
Ann M. Lees - Brookline MA, US
Robert S. Lees - Brookline MA, US
Simon W. Law - Lexington MA, US
Anibal A. Arjona - Boston MA, US
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
A61K 51/10
G01N 33/53
US Classification:
424 153, 4241331, 4241421, 5303873, 53038815
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
7402395, Jul 22, 2008
Filed:
Sep 24, 2003
Appl. No.:
10/671242
Inventors:
Ann M. Lees - Brookline MA, US
Robert S. Lees - Brookline MA, US
Simon W. Law - Lexington MA, US
Anibal A. Arjona - Boston MA, US
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
G01N 33/53
C07K 14/00
US Classification:
435 71, 530350, 530300
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
7807384, Oct 5, 2010
Filed:
Jun 12, 2008
Appl. No.:
12/137832
Inventors:
Ann M. Lees - Brookline MA, US
Robert S. Lees - Brookline MA, US
Simon W. Law - Lexington MA, US
Anibal A. Arjona - Boston MA, US
Assignee:
Boston Heart Foundation, Inc. - Cambridge MA
International Classification:
G01N 33/53
C07K 1/00
US Classification:
435 71, 530359
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.

Novel Low Density Lipoprotein Binding Proteins And Their Use In Diagnosing And Treating Atherosclerosis

View page
US Patent:
20020052033, May 2, 2002
Filed:
Sep 24, 2001
Appl. No.:
09/962055
Inventors:
Ann Lees - Brookline MA, US
Robert Lees - Brookline MA, US
Simon Law - Lexington MA, US
Anibal Arjona - Boston MA, US
Assignee:
Boston Heart Foundation, Inc., a Massachusetts corporation
International Classification:
C12N009/16
C12N009/64
C07H021/04
C12N005/06
C12P021/02
US Classification:
435/196000, 435/226000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.
Ann M Lees from Brookline, MA, age ~89 Get Report